Through the EV100 initiative, more than 100 organizations globally, including GlaxoSmithKline, have committed to transition nearly 5 million vehicles to EVs by 2030.  -  Photo courtesy of ARI.

Through the EV100 initiative, more than 100 organizations globally, including GlaxoSmithKline, have committed to transition nearly 5 million vehicles to EVs by 2030.

Photo courtesy of ARI.

ARI, a global fleet management provider specializing in complex car and truck fleets, and Enel X, the advanced energy services arm of the Enel Group, announced a collaboration with GlaxoSmithKline (GSK) to transition the healthcare company’s North American fleet to 100% electric vehicles (EVs) by 2030. According to the statement, the partnership will help GSK deploy about 100 electric and hybrid plug-in vehicle and installation charging locations, including the installation of JuiceBox smart charging stations and JuiceNetFleet IoT software.

“Electric vehicles continue to generate a significant amount of interest as a growing number of organizations look to integrate these vehicles into their fleet mix as part of their company’s overall sustainability strategy,” said Emily Graham, Holman’s director of sustainability, in the statement. “I think it is safe to say it’s no longer a question of if EVs will play a significant role in fleet operations, but more so what’s the speed at which it happens. As we explore potential electrification projects with our customers, it’s a very consultative conversation and being able to align with premier providers from across the industry such as Enel X makes implementing a comprehensive sustainability program as seamless as possible for fleet operators.”

“As more corporate fleets and rental car companies choose to go electric, these businesses will play a pivotal role in accelerating the transition of millions of cars and trucks to zero-emission,” added Giovanni Bertolino, head of e-Mobility, Enel X North America. “We are thrilled to collaborate with ARI and Holman to help support GSK’s fleet electrification goals and look forward to scaling smart charging services across their portfolio of vehicles and use cases. Through this project, we’re providing an intelligent, comprehensive sustainability solution that will deliver tangible environmental and economic results.”

“As a global science-based healthcare company, GSK knows the importance of protecting and restoring the planet’s health in order to protect and improve people’s health,” said Henry Rogers, director of fleet, GSK. “Our goal is to have a net zero impact on climate by 2030, and the EV100 initiative aims to deliver benefits to both climate and health by reducing air pollution from vehicles. This is an exciting step for our commercial fleet that also provides a seamless experience for our people.”

0 Comments